Professor Gareth Evans trained at St Mary's Hospital Medical School, London (1978-83). He held a RAMC Cadetship (1980). He has established a national and international reputation in clinical and research aspects of cancer genetics, particularly in neurofibromatosis and breast cancer. He has developed a clinical service for cancer genetics in the North West region of England, which is nationally regarded. He is an important opinion leader nationally through membership of committees and was chairman of the NICE Familial Breast Cancer Guideline Development Group (2002-2010) and, since 2011, clinical lead. He lectures throughout the UK and internationally on hereditary breast cancer and cancer syndromes. He has developed a national training programme for clinicians, nurses and genetic counsellors in breast cancer genetics and established a system for risk assessment and counselling for breast cancer.
Professor Evans has published 477 peer reviewed research publications; 182 as first or senior author. He has published over 75 reviews and chapters and has had a book published by Oxford University Press on familial cancer. He has an ISI web of knowledge H-index of 67 having only published his first article in 1990. In the last five years he has raised over £10 million in grants for multicentre and local studies – approximately £5 million to Manchester. He is Chief Investigator on a £1.59 million NIHR programmme grant (2009-2014) on breast cancer risk prediction.
Leads the national Neurofibromatosis type 2 service and participates in three multidisciplinary team meetings/clinics monthly.
He also works in the National Complex NF1 service, undertaking clinics on atypical neurofibromatosis.
3rd August 2018: Manchester researchers discover BRCA1-linked mechanism
7th February 2018: Genetic test could give women a more accurate breast cancer risk
30th January 2017: Video gives insight into the future of Cancer Prevention and Early Detection